Blockade of Adhesion of Sickle Cells to Endothelium by Monoclonal Antibodies
- 22 June 2000
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 342 (25) , 1910-1912
- https://doi.org/10.1056/nejm200006223422512
Abstract
Red cells that contain sickle hemoglobin tend to acquire an abnormal, sickled shape when their mutant hemoglobin polymerizes as a result of low oxygen tension. In the classic view of sickle cell disease pathophysiology, it is this deoxygenation-induced sickling of red cells that plugs blood vessels, precipitating a vaso-occlusive event, which is most commonly manifested clinically as an acute painful episode. This simple concept belies the complexity of vaso-occlusion in sickle cell disease, as shown by research over the past two decades, which has added to our understanding of the problem. It is now recognized that additional factors probably contribute . . .Keywords
This publication has 4 references indexed in Scilit:
- Monoclonal antibodies to αVβ3 (7E3 and LM609) inhibit sickle red blood cell–endothelium interactions induced by platelet-activating factorBlood, 2000
- Perspectives series: cell adhesion in vascular biology. Adhesive interactions of sickle erythrocytes with endothelium.Journal of Clinical Investigation, 1997
- The endothelial biology of sickle cell diseaseJournal of Laboratory and Clinical Medicine, 1997
- Erythrocytic and Vascular Factors Influencing the Microcirculatory Behavior of Blood in Sickle Cell AnemiaaAnnals of the New York Academy of Sciences, 1989